https://www.thebody.com/category/tivicay-dolutegravir/tag/news

The Latest

Dovato Is a Newly Approved Two-Drug HIV Regimen. Do Fewer Drugs Mean a Lower-Cost HIV Treatment? Img

Dovato Is a Newly Approved Two-Drug HIV Regimen. Do Fewer Drugs Mean a Lower-Cost HIV Treatment?

Advocates say the price is a step in the right direction. But does it go far enough?

By Tim Murphy
Q&A on Dolutegravir Use in Women of Childbearing Age Img

Q&A on Dolutegravir Use in Women of Childbearing Age

Questions and answers on potential risk of neural tube defects in infants born to women who were taking dolutegravir (DTG) at the time of conception.

By World Health Organization